RT Journal Article
T1 Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.
A1 Franch-Nadal, Josep
A1 Caballeria, Llorenç
A1 Mata-Cases, Manel
A1 Mauricio, Didac
A1 Giraldez-García, Carolina
A1 Mancera, José
A1 Goday, Albert
A1 Mundet-Tudurí, Xavier
A1 Regidor, Enrique
A1 PREDAPS Study Group, 
AB We evaluated the ability of the Fatty Liver Index (FLI), a surrogate marker of hepatic steatosis, to predict the development of type 2 diabetes (T2D) at 3 years follow-up in a Spanish cohort with prediabetes from a prospective observational study in primary care (PREDAPS). FLI was calculated at baseline for 1,142 adult subjects with prediabetes attending primary care centers, and classified into three categories: FLI  The proportion of subjects with prediabetes and hepatic steatosis (FLI ≥60) at baseline was 55.7%. The incidence rate of T2D at 3 years follow-up was 1.3, 2.9 and 6.0 per 100 person-years for FLI60 and FLI ≥60, respectively. The most significant variables increasing the risk of developing T2D were metabolic syndrome (hazard ratio [HR] = 3.02; 95% confidence interval [CI] = 2.14-4.26) and FLI ≥60 (HR = 4.52; 95%CI = 2.10-9.72). Moreover, FLI ≥60 was independently associated with T2D incidence: the HR was 4.97 (95% CI: 2.28-10.80) in the base regression model adjusted by sex, age and educational level, and 3.21 (95%CI: 1.45-7.09) in the fully adjusted model. FLI may be considered an easy and valuable early indicator of high risk of incident T2D in patients with prediabetes attended in primary care, which could allow the adoption of effective measures needed to prevent and reduce the progression of the disease.
YR 2018
FD 2018-06-01
LK http://hdl.handle.net/10668/12529
UL http://hdl.handle.net/10668/12529
LA en
DS RISalud
RD Apr 28, 2025